HF
SXTC icon

HRT Financial’s China SXT Pharmaceuticals SXTC Stock Holding History

HRT Financial’s Portfolio SXTC Stock Details SXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$42K – 4019
2025
Q3 		$42K Buy
+2
New +$39.5K ﹤0.01% 2619
2023
Q4 		– Hold
0
– -$5K – 3050
2023
Q3 		– Hold
0
– – – 2186
2022
Q4 		– Hold
0
– -$8K – 3120
2022
Q3 		– Hold
0
– – – 2554
2021
Q4 		– Hold
0
– -$86K – 4050
2021
Q3 		– Hold
0
– – – 2938
2021
Q2 		– Hold
0
– – – 2574
2021
Q1 		– Hold
0
– – – 2344
2020
Q4 		– Hold
0
– -$80K – 2442
2020
Q3 		– Hold
0
– – – 1584
2020
Q2 		– Hold
0
– – – 1323

Other funds holding SXTC

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's SXTC Position: Q4 2025 in Review

HRT Financial sold out of China SXT Pharmaceuticals (SXTC) in Q4 2025, closing a stake of 2 shares — an estimated $42K sold.

HRT Financial first reported a position in SXTC in Q3 2025 and held it in 1 quarter. The position peaked at $42K in Q3 2025. 5 funds tracked by Wall St. Rank hold SXTC as of Q4 2025.

  • HRT Financial reported no remaining China SXT Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 2 China SXT Pharmaceuticals shares in Q4 2025, an estimated $42K.
  • HRT Financial first reported a position in China SXT Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • HRT Financial's China SXT Pharmaceuticals position peaked at $42K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.